Financhill
Back

Corcept Therapeutics 10K Form

Buy
73

CORT
Corcept Therapeutics

Last Price:
34.06
Seasonality Move:
4.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive CORT News And Ratings

See the #1 stock for the next 7 days that we like better than CORT

CORT Financial Statistics

Sales & Book Value

Annual Sales: $482.38M
Cash Flow: $23.76M
Price / Cash Flow: 29.95
Annual Sales: $5.27
Price / Book: 6.44

Profitability

EPS (TTM): 1.06000
Net Income (TTM): $118.02M
Gross Margin: $475.89M
Return on Equity: 23.92%
Return on Assets: 19.58%

Corcept Therapeutics Earnings Forecast

Key Corcept Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 19 years for CORT is 98.66%.
  • The Selling, General & Administrative Expenses for CORT have been equal to 38.20% of Gross Profit Margin.
  • The Research & Development expenses have been 38.22% of Revenue.
  • The Interest Expense is 0.04% of Operating Income.
  • The Net Earning history of CORT is 22.00% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 12 years.

Corcept Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CORT
CUSIP: 218352
Website: corcept.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.18
Quick Ratio: 4.86

Price-to-Earnings

Trailing P/E Ratio: 36.04
Forward P/E Ratio: 27.38

CORT Technical Analysis vs Fundamental Analysis

Buy
73
Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics a Buy or a Sell?